14 November 2016 |
ASIT biotech takes important steps in US clinical development of gp-ASIT+™, its lead drug candidate for grass pollen rhinitis Download the press release |
|||
ASIT biotech takes important steps in US clinical development of gp-ASIT+™, its lead drug candidate for grass pollen rhinitis
- Details
- Category: Press Releases